Tissue Engineering Approaches to Treat COPD
This research is investigating Chronic Obstructive Pulmonary Disease (COPD) by comparing lung tissue from people who have COPD (with conditions like chronic bronchitis or emphysema) with tissue from healthy individuals. The aim is to understand the differences in these tissues at a detailed level, including their strength and chemical makeup. Researchers are also working to grow new lung cells and tissues in the lab, which they call 'tissue-engineered lung equivalents' (TELEs). These TELEs are designed to match the properties of healthy and diseased lung tissue. The ultimate goal is to test how well these lab-grown tissues can integrate with lung tissue, potentially paving the way for future treatments for lung damage caused by COPD.
At a glance
What is this study about?
This study is trying to understand more about Chronic Obstructive Pulmonary Disease, or COPD, which is a common lung condition. COPD makes it hard to breathe because it causes progressive damage to the lungs. This damage can lead to breathlessness, reduced ability to exercise, and a lower quality of life. Current treatments can help manage symptoms but don't repair the actual lung damage.
The researchers are studying lung tissue samples from two groups: people with COPD (specifically those with chronic bronchitis or emphysema) and people without COPD (the 'control' group). By comparing these tissues, they hope to learn more about how COPD affects the lungs at a very detailed level. They are looking at the strength, flexibility, and chemical makeup of the tissue.
Another important part of the study involves growing new lung cells and tissues in the laboratory. They call these 'tissue-engineered lung equivalents' or TELEs. These TELEs are carefully designed to have similar characteristics to real lung tissue. The scientists are then testing how well these lab-grown tissues can connect and work with natural lung tissue in a controlled lab setting. This research is a first step towards potentially developing new ways to repair damaged lungs in the future.
Key takeaways
- This study helps scientists understand COPD by comparing lung tissue from people with and without the condition.
- Researchers are also developing lab-grown lung tissues (TELEs) that could be used for future treatments.
- Participation involves donating a small piece of leftover lung tissue from a planned surgery.
- There are no direct risks or medical benefits to you, but your contribution helps advance medical knowledge.
- Your consent is voluntary, and you can withdraw at any time without affecting your medical care.
Who may be eligible?
To join this study, participants must be at least 18 years old and be able to understand and sign a consent form. They must also be scheduled to have lung tissue removed as part of their standard medical care, for example, during surgery.
People will not be able to take part if they are unable to give informed consent, or if they have other significant long-term health conditions or lung diseases (like infections, asthma, or fibrotic lung diseases) that are different from the reason they are having surgery.
After surgery, if not enough tissue is available for the study after the doctors have taken what they need for diagnosis, then that person's tissue cannot be included.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Are you able to understand and sign a consent form?
- Are you scheduled to have a surgery where lung tissue will be removed as part of your standard medical care?
- Do you have any other significant long-term lung conditions like asthma or infections (other than what you're having surgery for)?
What does participation involve?
If you are eligible and agree to take part, your participation would involve providing consent for researchers to use a small amount of leftover lung tissue from a planned surgery. This is tissue that would otherwise be discarded after your medical care. There are no additional hospital visits or assessments required beyond your scheduled surgery, and no changes to your medication. The study itself is conducted in the laboratory using the donated tissue, so there will be no direct follow-up for you related to this research. The total duration of your personal involvement is limited to the consent process and the collection of tissue during your surgery.
Potential risks and benefits
Locations (1)
- University Hospitals of North Midlands NHS TrustVerified postcodeStoke-on-Trent, United Kingdom
Common questions
What is COPD?
COPD stands for Chronic Obstructive Pulmonary Disease. It's a common lung condition that makes it difficult to breathe, often due to long-term lung damage.
Will this study affect my surgery?
No, participating in this study will not change your planned surgery or your medical care in any way. It only uses some leftover tissue from your surgery.
What are 'tissue-engineered lung equivalents'?
These are lab-grown lung cells and tissues that researchers are creating to act like real lung tissue. They are being developed to understand and potentially repair damaged lungs.
Will I get any results from the study?
Because this research uses anonymous tissue samples in the lab, there won't be any individual results provided to participants. The findings will contribute to general scientific knowledge.
Is my personal information kept private?
Yes, all tissue samples and any related information will be handled confidentially and anonymously, meaning your identity will not be linked to the research findings.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.